Intersect ENT (XENT) Tops Q3 EPS by 5c

Intersect ENT (NASDAQ: XENT) reported Q3 EPS of ($0.22), $0.05 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $18.5 million versus the consensus estimate of $17.84 million.

For earnings history and earnings-related data on Intersect ENT (XENT) click here.

You May Also Be Interested In

• Cerebras CEO says investors misunderstood margin guidance
• BMO Capital on FedEx (FDX): 'Guidance Appears Consistent With Our Forecasts'
• All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade